neoadjuvant immunotherapy in tnbc and targeted lnd in breast cancer: 2023 best of breast conference
Published 1 year ago • 258 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
6:29
hot topics in advanced breast cancer: 2023 best of breast conference
-
1:35
issues in triple negative breast cancer: 2023 best of breast conference
-
2:10
testing and targeted therapy in triple negative breast cancer: 2023 west oncology
-
2:25
metastatic triple negative breast cancer: 2023 best of breast conference
-
1:08:58
tnbc current and emerging therapeutic strategies | 2023 best of breast conference
-
20:55
lightning updates | 2023 best of breast conference
-
3:37
tnbc: immunotherapy in the neoadjuvant setting
-
22:54
testing, treating, and targeting triple negative breast cancer | 2023 west oncology conference
-
1:00:01
her2 mbc | 2023 best of breast conference
-
53:17
patients with high risk features | 2023 best of breast conference
-
0:41
the importance of brca-1 testing in triple negative breast cancer
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
1:00
utilizing neoadjuvant immunotherapies in patients with er , her2- primary breast cancer
-
0:53
keynote-522 demonstrates potential for immunotherapy in triple-negative breast cancer
-
35:58
diversity, inclusion, and equity in cancer care | 2023 best of breast conference
-
1:00:46
triple negative breast cancer case panel discussion | 2022 best of breast conference
-
0:56
pembrolizumab as adjuvant therapy for tnbc
-
1:16
dr. tolaney on platinum-based therapy in neoadjuvant setting of tnbc
-
2:21
the challenges of treating early-stage tnbc